1. Huang, Chengchi, Ji, Liyang, Kaur, Avinash, Webster, Keith A, Li, Wei. 2023. Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice. In Biomedicines, 11, . doi:10.3390/biomedicines11071910. https://pubmed.ncbi.nlm.nih.gov/37509549/
2. Ji, Liyang, Waduge, Prabuddha, Hao, Lili, Webster, Keith A, Li, Wei. . Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36, e22106. doi:10.1096/fj.202101085RR. https://pubmed.ncbi.nlm.nih.gov/34918375/
3. Tanabe, Atsushi, Yanagiya, Takahiro, Iida, Aritoshi, Nakamura, Yusuke, Hotta, Kikuko. 2007. Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity. In The Journal of clinical endocrinology and metabolism, 92, 1145-54. doi:. https://pubmed.ncbi.nlm.nih.gov/17200173/
4. Wang, Yi, Ji, Nan, Wang, Junmei, Zhang, Yang, Zhang, Liwei. 2021. SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes. In Pathology oncology research : POR, 27, 594931. doi:10.3389/pore.2021.594931. https://pubmed.ncbi.nlm.nih.gov/34257545/
5. Dai, Chang, Waduge, Prabuddha, Ji, Liyang, Webster, Keith A, Li, Wei. 2022. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. In Cellular and molecular life sciences : CMLS, 79, 63. doi:10.1007/s00018-021-04111-2. https://pubmed.ncbi.nlm.nih.gov/35006382/
6. Ji, Liyang, Waduge, Prabuddha, Wan, Wencui, Chen, Rui, Li, Wei. 2022. Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization. In The FEBS journal, 289, 3521-3534. doi:10.1111/febs.16356. https://pubmed.ncbi.nlm.nih.gov/35038348/
7. Wang, Yue, Cui, Ming, Cai, Xiaoli, Zhang, Xiaodong, Ye, Lihong. 2014. The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells. In Cancer letters, 352, 169-78. doi:10.1016/j.canlet.2014.05.007. https://pubmed.ncbi.nlm.nih.gov/24882622/
8. Liu, Jun, Hu, Sile, Chen, Lingyan, van Duijn, Cornelia M, Howson, Joanna M M. 2023. Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets. In medRxiv : the preprint server for health sciences, , . doi:10.1101/2023.11.30.23299247. https://pubmed.ncbi.nlm.nih.gov/38076879/
智鼠故事 
